LG Corp.
A multinational holding company with subsidiaries in electronics, chemicals, and telecom.
003550 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003550001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 영등포구 여의대로 128, 영등포구
- Website:
- https://www.lgcorp.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of domestic appliances
Description
LG Corp. is a multinational holding company that manages a diverse portfolio of subsidiary companies operating globally. The corporation's primary business areas are electronics, chemicals, and telecommunications. Key affiliates include LG Electronics, a leading manufacturer of consumer electronics and home appliances; LG Chem, a provider of advanced materials, petrochemicals, and life science products; and LG Energy Solution, a major developer of lithium-ion batteries for electric vehicles and energy storage systems. Other significant subsidiaries operate in sectors such as displays (LG Display), electronic components (LG Innotek), telecommunications services (LG U+), and IT solutions (LG CNS).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | HTML • 3.5 MB | ||
| 2022-11-11 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 미국 임상 3상 시험계획 승인)
|
Korean | HTML • 10.1 KB | ||
| 2022-11-10 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | HTML • 16.0 KB | ||
| 2022-11-08 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)( Tigulixostat(통풍치료제)의 다국가 임상3상 시험 중국 참여 중단)
|
Korean | HTML • 8.8 KB | ||
| 2022-10-28 00:00 |
결산실적공시예고(안내공시)
|
Korean | HTML • 4.5 KB | ||
| 2022-10-18 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(한국 임상 3상 시험계획 신청)
|
Korean | HTML • 8.8 KB | ||
| 2022-10-18 00:00 |
타법인주식및출자증권취득결정(자회사의 주요경영사항)
|
Korean | HTML • 22.4 KB | ||
| 2022-10-12 00:00 |
[기재정정]타법인주식및출자증권취득결정(자회사의 주요경영사항)
|
Korean | HTML • 24.6 KB | ||
| 2022-09-28 00:00 |
지속가능경영보고서등관련사항(자율공시)
|
Korean | HTML • 9.5 KB | ||
| 2022-09-28 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 미국 임상 3상 시험계획 승인)
|
Korean | HTML • 9.4 KB | ||
| 2022-09-16 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 유럽 임상 3상 시험계획 신청)
|
Korean | HTML • 8.9 KB | ||
| 2022-09-05 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 중국 임상 3상 시험계획 신청)
|
Korean | HTML • 8.8 KB | ||
| 2022-09-01 00:00 |
투자판단관련주요경영사항(자회사의 주요경영사항)(Tigulixostat(통풍치료제) 미국 임상 3상 시험계획 신청)
|
Korean | HTML • 8.7 KB | ||
| 2022-08-31 00:00 |
대규모기업집단현황공시[분기별공시(대표회사용)]
|
English | HTML • 2.8 MB | ||
| 2022-08-30 00:00 |
신탁계약에의한취득상황보고서
|
Korean | HTML • 58.4 KB |
Automate Your Workflow. Get a real-time feed of all LG Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for LG Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for LG Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
